Biomerica Inc
Biomerica, Inc., a biomedical technology company, engages in developing, patenting, manufacturing, and marketing diagnostic and therapeutic products for the detection and treatment of medical conditions and diseases worldwide. The company's diagnostic test kits are used to analyze blood, urine, nasal or fecal specimens from patients in the diagnosis of various diseases, food intolerances, and oth… Read more
Biomerica Inc (BMRA) - Net Assets
Latest net assets as of November 2025: $4.43 Million USD
Based on the latest financial reports, Biomerica Inc (BMRA) has net assets worth $4.43 Million USD as of November 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($6.03 Million) and total liabilities ($1.60 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $4.43 Million |
| % of Total Assets | 73.5% |
| Annual Growth Rate | -1.01% |
| 5-Year Change | -55.51% |
| 10-Year Change | -21.37% |
| Growth Volatility | 51.86 |
Biomerica Inc - Net Assets Trend (1986–2025)
This chart illustrates how Biomerica Inc's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Biomerica Inc (1986–2025)
The table below shows the annual net assets of Biomerica Inc from 1986 to 2025.
| Year | Net Assets | Change |
|---|---|---|
| 2025-05-31 | $4.11 Million | -37.72% |
| 2024-05-31 | $6.59 Million | -43.78% |
| 2023-05-31 | $11.72 Million | +40.83% |
| 2022-05-31 | $8.32 Million | -9.78% |
| 2021-05-31 | $9.23 Million | -35.08% |
| 2020-05-31 | $14.21 Million | +257.02% |
| 2019-05-31 | $3.98 Million | -7.97% |
| 2018-05-31 | $4.33 Million | -3.64% |
| 2017-05-31 | $4.49 Million | -14.01% |
| 2016-05-31 | $5.22 Million | -6.79% |
| 2015-05-31 | $5.60 Million | -5.31% |
| 2014-05-31 | $5.91 Million | +1.36% |
| 2013-05-31 | $5.83 Million | +17.20% |
| 2012-05-31 | $4.98 Million | +14.97% |
| 2011-05-31 | $4.33 Million | +6.58% |
| 2010-05-31 | $4.06 Million | -6.56% |
| 2009-05-31 | $4.35 Million | +11.95% |
| 2008-05-31 | $3.88 Million | +121.62% |
| 2007-05-31 | $1.75 Million | +64.75% |
| 2006-05-31 | $1.06 Million | -69.89% |
| 2005-05-31 | $3.53 Million | +0.55% |
| 2004-05-31 | $3.51 Million | +8.25% |
| 2003-05-31 | $3.25 Million | -1.51% |
| 2002-05-31 | $3.30 Million | -6.37% |
| 2001-05-31 | $3.52 Million | -28.28% |
| 2000-05-31 | $4.91 Million | -20.84% |
| 1999-05-31 | $6.20 Million | 0.00% |
| 1998-05-31 | $6.20 Million | +5.08% |
| 1997-05-31 | $5.90 Million | +43.90% |
| 1996-05-31 | $4.10 Million | +28.13% |
| 1995-05-31 | $3.20 Million | -3.03% |
| 1994-05-31 | $3.30 Million | +17.86% |
| 1993-05-31 | $2.80 Million | +21.74% |
| 1992-05-31 | $2.30 Million | -8.00% |
| 1991-05-31 | $2.50 Million | -45.65% |
| 1990-05-31 | $4.60 Million | +39.39% |
| 1989-05-31 | $3.30 Million | -19.51% |
| 1988-05-31 | $4.10 Million | -10.87% |
| 1987-05-31 | $4.60 Million | -24.59% |
| 1986-05-31 | $6.10 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Biomerica Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 4846800000.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (May 2025)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $203.00K | 4.95% |
| Other Comprehensive Income | $-105.00K | -2.56% |
| Other Components | $57.17 Million | 1392.81% |
| Total Equity | $4.11 Million | 100.00% |
Biomerica Inc Competitors by Market Cap
The table below lists competitors of Biomerica Inc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Bodegas Riojanas S.A.
MC:RIO
|
$5.37 Million |
|
Tifa Finance Tbk
JK:TIFA
|
$5.37 Million |
|
Altamin Ltd
AU:AZI
|
$5.38 Million |
|
Cosigo Resources Ltd.
V:CSG
|
$5.38 Million |
|
Gillanders Arbuthnot & Company Limited
NSE:GILLANDERS
|
$5.37 Million |
|
C-SITE Co., Ltd.
KQ:109670
|
$5.37 Million |
|
Avenir Telecom S.A
PA:AVT
|
$5.37 Million |
|
Sappi Ltd
JSE:SAP
|
$5.37 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Biomerica Inc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 6,591,000 to 4,105,000, a change of -2,486,000 (-37.7%).
- Net loss of 4,973,000 reduced equity.
- New share issuances of 2,143,000 increased equity.
- Other comprehensive income decreased equity by 3,000.
- Other factors increased equity by 347,000.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-4.97 Million | -121.14% |
| Share Issuances | $2.14 Million | +52.2% |
| Other Comprehensive Income | $-3.00K | -0.07% |
| Other Changes | $347.00K | +8.45% |
| Total Change | $- | -37.72% |
Book Value vs Market Value Analysis
This analysis compares Biomerica Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 1.16x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has increased from 0.98x to 1.16x over the analyzed period, suggesting growing market confidence.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 1986-05-31 | $2.12 | $2.08 | x |
| 1987-05-31 | $1.56 | $2.08 | x |
| 1988-05-31 | $1.43 | $2.08 | x |
| 1989-05-31 | $1.10 | $2.08 | x |
| 1990-05-31 | $0.84 | $2.08 | x |
| 1991-05-31 | $0.60 | $2.08 | x |
| 1992-05-31 | $0.43 | $2.08 | x |
| 1993-05-31 | $0.42 | $2.08 | x |
| 1994-05-31 | $0.48 | $2.08 | x |
| 1995-05-31 | $0.42 | $2.08 | x |
| 1996-05-31 | $0.56 | $2.08 | x |
| 1997-05-31 | $0.93 | $2.08 | x |
| 1998-05-31 | $0.93 | $2.08 | x |
| 1999-05-31 | $0.95 | $2.08 | x |
| 2000-05-31 | $0.62 | $2.08 | x |
| 2001-05-31 | $0.31 | $2.08 | x |
| 2002-05-31 | $0.24 | $2.08 | x |
| 2003-05-31 | $0.21 | $2.08 | x |
| 2004-05-31 | $0.16 | $2.08 | x |
| 2005-05-31 | $0.16 | $2.08 | x |
| 2006-05-31 | $0.17 | $2.08 | x |
| 2007-05-31 | $0.27 | $2.08 | x |
| 2008-05-31 | $0.56 | $2.08 | x |
| 2009-05-31 | $0.62 | $2.08 | x |
| 2010-05-31 | $0.61 | $2.08 | x |
| 2011-05-31 | $0.65 | $2.08 | x |
| 2012-05-31 | $0.70 | $2.08 | x |
| 2013-05-31 | $0.78 | $2.08 | x |
| 2014-05-31 | $0.80 | $2.08 | x |
| 2015-05-31 | $0.74 | $2.08 | x |
| 2016-05-31 | $0.68 | $2.08 | x |
| 2017-05-31 | $0.54 | $2.08 | x |
| 2018-05-31 | $0.50 | $2.08 | x |
| 2019-05-31 | $0.43 | $2.08 | x |
| 2020-05-31 | $1.40 | $2.08 | x |
| 2021-05-31 | $0.77 | $2.08 | x |
| 2022-05-31 | $0.66 | $2.08 | x |
| 2023-05-31 | $0.83 | $2.08 | x |
| 2024-05-31 | $0.39 | $2.08 | x |
| 2025-05-31 | $1.79 | $2.08 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Biomerica Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -121.14%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -93.64%
- • Asset Turnover: 0.89x
- • Equity Multiplier: 1.45x
- Recent ROE (-121.14%) is below the historical average (-27.95%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 1986 | -31.15% | -111.76% | 0.23x | 1.23x | $-2.51 Million |
| 1987 | -28.26% | -68.42% | 0.30x | 1.37x | $-1.76 Million |
| 1988 | -9.76% | -28.57% | 0.29x | 1.17x | $-810.00K |
| 1989 | -27.27% | -75.00% | 0.32x | 1.15x | $-1.23 Million |
| 1990 | -21.43% | -7.32% | 0.91x | 3.21x | $-880.00K |
| 1991 | -66.67% | -11.54% | 1.42x | 4.06x | $-1.38 Million |
| 1992 | -69.23% | -11.54% | 1.22x | 4.92x | $-1.03 Million |
| 1993 | -33.33% | -5.00% | 1.27x | 5.25x | $-520.00K |
| 1995 | 7.14% | 1.09% | 1.59x | 4.14x | $-40.00K |
| 1996 | 20.00% | 4.21% | 1.56x | 3.05x | $200.00K |
| 1997 | 11.11% | 4.35% | 1.24x | 2.06x | $40.00K |
| 1998 | 2.70% | 1.06% | 1.25x | 2.03x | $-270.00K |
| 1999 | -2.63% | -1.15% | 1.12x | 2.05x | $-480.00K |
| 2000 | -139.18% | -48.43% | 1.19x | 2.41x | $-4.17 Million |
| 2001 | -181.44% | -29.89% | 1.67x | 3.63x | $-2.82 Million |
| 2002 | -34.75% | -4.89% | 1.63x | 4.36x | $-541.81K |
| 2003 | -20.35% | -2.47% | 1.63x | 5.04x | $-333.85K |
| 2004 | -24.10% | -2.43% | 1.65x | 6.01x | $-315.83K |
| 2005 | 15.41% | 1.75% | 1.60x | 5.50x | $56.95K |
| 2006 | 21.65% | 3.20% | 2.96x | 2.28x | $123.90K |
| 2007 | 30.63% | 9.34% | 1.78x | 1.84x | $361.62K |
| 2008 | 44.03% | 34.71% | 0.96x | 1.32x | $1.32 Million |
| 2009 | 8.15% | 7.18% | 0.96x | 1.18x | $-80.62K |
| 2010 | -8.16% | -6.53% | 1.01x | 1.23x | $-737.74K |
| 2011 | 3.64% | 3.21% | 0.99x | 1.14x | $-275.59K |
| 2012 | 11.02% | 9.02% | 1.09x | 1.12x | $50.57K |
| 2013 | 9.20% | 8.30% | 1.01x | 1.10x | $-46.54K |
| 2014 | -3.65% | -4.21% | 0.79x | 1.09x | $-807.11K |
| 2015 | -5.92% | -6.68% | 0.81x | 1.09x | $-891.46K |
| 2016 | -28.73% | -29.18% | 0.90x | 1.10x | $-2.02 Million |
| 2017 | -20.24% | -15.69% | 1.15x | 1.12x | $-1.36 Million |
| 2018 | -33.89% | -26.34% | 1.07x | 1.21x | $-1.90 Million |
| 2019 | -60.11% | -46.01% | 0.99x | 1.32x | $-2.79 Million |
| 2020 | -16.46% | -34.95% | 0.39x | 1.21x | $-3.76 Million |
| 2021 | -80.70% | -103.43% | 0.61x | 1.28x | $-8.37 Million |
| 2022 | -54.43% | -24.01% | 1.66x | 1.37x | $-5.36 Million |
| 2023 | -60.90% | -133.73% | 0.37x | 1.23x | $-8.31 Million |
| 2024 | -90.70% | -110.40% | 0.59x | 1.40x | $-6.64 Million |
| 2025 | -121.14% | -93.64% | 0.89x | 1.45x | $-5.38 Million |
Industry Comparison
This section compares Biomerica Inc's net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $694,749,556
- Average return on equity (ROE) among peers: -25.46%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Biomerica Inc (BMRA) | $4.43 Million | -31.15% | 0.36x | $5.37 Million |
| Advanced Biomedical Technologies Inc (ABMT) | $-4.46 Million | 0.00% | 0.00x | $14.18K |
| Abbott Laboratories (ABT) | $4.82 Billion | 39.04% | 1.31x | $191.37 Billion |
| Acarix AB (publ) (ACIXF) | $1.93 Million | -127.02% | 0.21x | $26.42 Million |
| Adagio Medical Holdings, Inc Common Stock (ADGM) | $-72.62 Million | 0.00% | 0.00x | $4.05 Million |
| Adm Tronics Unltd (ADMT) | $-12.69K | 0.00% | 0.00x | $3.17 Million |
| Aethlon Medical Inc (AEMD) | $-3.07 Million | 0.00% | 0.00x | $2.79 Million |
| Acutus Medical Inc (AFIB) | $126.58 Million | -80.56% | 0.52x | $732.88K |
| Adapthealth Corp (AHCO) | $2.07 Billion | 7.56% | 1.54x | $914.25 Million |
| Allied Healthcare Products Inc. (AHPIQ) | $8.88 Million | -33.95% | 1.22x | $726.24 |
| 20/20 Biolabs, Inc. Common Stock (AIDX) | $3.39 Million | -59.65% | 0.38x | $9.18 Million |